The latest closing stock price for Inozyme Pharma as of June 23, 2025 is 3.99.
An investor who bought $1,000 worth of Inozyme Pharma stock at the IPO in 2020 would have $-773 today, roughly -1 times their original investment - a -25.63% compound annual growth rate over 5 years.
The all-time high Inozyme Pharma stock closing price was 30.20 on September 01, 2020.
The Inozyme Pharma 52-week high stock price is 6.24, which is 56.4% above the current share price.
The Inozyme Pharma 52-week low stock price is 0.72, which is 82% below the current share price.
The average Inozyme Pharma stock price for the last 52 weeks is 3.25.
An investor who bought $1,000 worth of Inozyme Pharma stock at the IPO in 2020 would have $-773 today, roughly -1 times their original investment - a -25.63% compound annual growth rate over 5 years.
The all-time high Inozyme Pharma stock closing price was 30.20 on September 01, 2020.
The Inozyme Pharma 52-week high stock price is 6.24, which is 56.4% above the current share price.
The Inozyme Pharma 52-week low stock price is 0.72, which is 82% below the current share price.
The average Inozyme Pharma stock price for the last 52 weeks is 3.25.